Gurgaon police authorities seized fake Mounjaro KwikPen injections valued at more than Rs 70,00,000 [1] during an operation in the National Capital Region.
The seizure highlights the growing danger of spurious medications entering the Indian market as demand for weight-loss and diabetes drugs rises. The circulation of counterfeit pharmaceuticals poses severe risks to patients who may receive ineffective or harmful substances instead of clinical treatment.
Police officials said the operation targeted an illegal drug racket operating within the NCR. The seized items consisted of tirzepatide injections, the active ingredient in Mounjaro, which are often sought after for medical weight loss, and the management of type 2 diabetes.
Investigators said the racket aimed to profit from the high demand for these specific medications. By producing and distributing fake versions of the KwikPen system, the operators were able to sell fraudulent products at a significant scale.
The crackdown is part of a broader effort by local authorities to combat the circulation of spurious medication and protect public health. Police said the investigation continues to identify the suppliers and distributors involved in the network.
Authorities said the counterfeit pens were designed to mimic the appearance of legitimate medical supplies. This deception makes it difficult for consumers to identify fake drugs without professional laboratory testing.
“Gurgaon police authorities seized fake Mounjaro KwikPen injections valued at more than Rs 70,00,000.”
The emergence of high-value counterfeit tirzepatide in India reflects a global trend where the popularity of GLP-1 receptor agonists creates a lucrative black market. Because these drugs require strict temperature controls and precise dosing, the use of fake injections can lead to unpredictable medical complications or a total lack of therapeutic effect, necessitating stricter pharmacy oversight in the NCR.
